Balanitis

2 papers1 finding

Human trial1
Humans1

Associations

1

SGLT2 inhibitors

upin humans1OR 1.72

1 study

SGLT2 inhibitors raise the risk of balanitis in humans (OR 1.72, CI: 1.11-2.64, p = 0.013).
“Balanitis (23 vs. 194 cases; OR 1.72, CI: 1.11-2.64, p = 0.013)”
Humansheart failure without diabetes, advanced kidney/liver disease, cancer, or immunodeficiency5-year follow-up
Increasing Risk of Fournier’s Gangrene and Other Rare Genital Infections in Heart Failure Patients with and without Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i): A Multicenter Cohort Study
AHA Scientific Sessions 2025 abstract3 Nov 2025

More on SGLT2 inhibitors

Latest

1 in 12 months

AHA Scientific Sessions 2025 Abstract3 Nov

Increasing Risk of Fournier’s Gangrene and Other Rare Genital Infections in Heart Failure Patients with and without Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i): A Multicenter Cohort Study

Cohort study in peopleHeart failure

The Journal of Clinical Endocrinology and Metabolism11 Jan

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

Randomised trial in 182 peopleDapagliflozin